James M Reuben

58PUBLICATIONS
377CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Sep 02, 2026
Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichment.

|Jul 08, 2026
Unbiased avidity-based isolation of antigen-specific T cells.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

|Apr 03, 2026
Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures.

Nan Deng, Fahriye Duzagac, Ana M Bolivar

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

Pageof 10

Frequent Collaborators

19 joint publications

Jianjun Zhang

15 joint publications

P Andy Futreal

14 joint publications

John V Heymach

12 joint publications

Alexander Lazar